Immunotherapeutic targeting of surfaceome heterogeneity in AML
Cell Reports · 2024-06 · 43 (6) · 114260
DOI: 10.1016/j.celrep.2024.114260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-06. Verfasst von Marie-Eve Bordeleau und 28 weiteren Autor:innen. Beteiligte Einrichtung: The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada. Electronic address: m…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Immunotherapy. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cole Foundation, Canada First Research Excellence Fund, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada. Electronic address: marie.eve.bordeleau@umontreal.ca.
- The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada.
- The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC H3T 1C5, Cana…
- The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC H1T 2M4, Canada.
- The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Department of Chemistry, Faculty of Arts and Science, Université de Montréal, Montréal, QC…
- The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Centre de Recherche du Centre Hospitalier Universitaire de Québec, Université Laval, Québec…
Förderung
- Cole Foundation
- Canada First Research Excellence Fund
- Canadian Institutes of Health Research
- Alliance de recherche numérique du Canada
- Fonds de Recherche du Québec - Santé
- Genome Canada
- Institut de Valorisation des Données
- Université de Montréal
Zitieren
APA
Bordeleau, M. E., Audemard, É., Métois, A., Theret, L., Lisi, V., Farah, A., Spinella, J. F., Chagraoui, J., Moujaber, O., Aubert, L., Khakipoor, B., Mallinger, L., Boivin, I., Mayotte, N., Hajmirza, A., Bonneil, É., Béliveau, F., Pfammatter, S., Feghaly, A., …, & Sauvageau, G. (2024). Immunotherapeutic targeting of surfaceome heterogeneity in AML. Cell Reports, 43(6), 114260. https://doi.org/10.1016/j.celrep.2024.114260
Vancouver
Bordeleau ME, Audemard É, Métois A, Theret L, Lisi V, Farah A, et al. Immunotherapeutic targeting of surfaceome heterogeneity in AML. Cell Reports. 2024;43(6):114260. doi:10.1016/j.celrep.2024.114260
BibTeX
@article{Bordeleau2024,
author = {Bordeleau, Marie-Eve and Audemard, Éric and Métois, Arnaud and Theret, Louis and Lisi, Véronique and Farah, Azer and Spinella, Jean-François and Chagraoui, Jalila and Moujaber, Ossama and Aubert, Léo and Khakipoor, Banafsheh and Mallinger, Laure and Boivin, Isabel and Mayotte, Nadine and Hajmirza, Azadeh and Bonneil, Éric and Béliveau, François and Pfammatter, Sybille and Feghaly, Albert and Boucher, Geneviève and Gendron, Patrick and Thibault, Pierre and Barabé, Frédéric and Lemieux, Sébastien and Richard-Carpentier, Guillaume and Hébert, Josée and Lavallée, Vincent-Philippe and Roux, Philippe P and Sauvageau, Guy},
title = {Immunotherapeutic targeting of surfaceome heterogeneity in AML},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {6},
pages = {114260},
doi = {10.1016/j.celrep.2024.114260}
}
EUVIMED